Trial · NCT05022563
Participant flow30
How many started, completed or left each group, period by period.
21 to 30 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | COMPLETED | NOAC-Based Therapy: Dabigatran | 2,103 | |
| Overall Study | COMPLETED | NOAC-Based Therapy: Edoxaban | 2,342 | |
| Overall Study | COMPLETED | NOAC-Based Therapy: Rivaroxaban | 26,276 | |
| Overall Study | COMPLETED | Parenteral Anticoagulants (PAC) Only | 8,783 | |
| Overall Study | NOT COMPLETED | Warfarin-Based Therapy | 0 | |
| Overall Study | NOT COMPLETED | Non-vitamin K Antagonist Oral Anticoagulants (NOAC)-Based Therapy: Apixaban | 0 | |
| Overall Study | NOT COMPLETED | NOAC-Based Therapy: Dabigatran | 0 | |
| Overall Study | NOT COMPLETED | NOAC-Based Therapy: Edoxaban | 0 | |
| Overall Study | NOT COMPLETED | NOAC-Based Therapy: Rivaroxaban | 0 | |
| Overall Study | NOT COMPLETED | Parenteral Anticoagulants (PAC) Only | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05022563/flow?page=2